CJC-1295 and ipamorelin oral spray formulations have become increasingly common in compounding practice, with growing clinical experience supporting their use particularly for patients where injection compliance is poor
de Alencar JCG, Moreira CL, Mller AD, Chaves CE, Fukuhara MA, da Silva EA, Miyamoto MFS, Pinto VB, Bueno CG, Neto FL, Gomez LM, Menezes MCS, Marchini JFM, Marino LO, Brando Neto RA, Souza HP (2021) Double-blind, randomized, placebo-controlled trial with N-acetylcysteine for treatment of severe acute respiratory syndrome caused by Coronavirus disease 2019 (COVID-19)
Improve insulin resistance Improve mobility with the patient of claudication Reduces symptoms of Parkinsons Disease Inhibits chemical-induced carcinogenesis Chelator of lead, mercury, cadmium, and arsenic Prevents radiation injury Levels decrease with age: cellular differentiation and may slow the aging process Maintain Optimal Health Improve Weakened Immune System Increase Energy Improve Sleep quality Improve Mood, motivation Improve Immune Function Improve Performance, Endurance Autoimmune Diseases Chronic Fatigue, Fibromyalgia Malabsorption, Irritable Bowel Chronic illness: diabetes, high blood pressure, high cholesterol, Frequency Colds, Chronic Allergies, Asthma Depression, Anxiety, Insomnia Autoimmune Disease: Thyroid Disease, MS, Parkinsons disease (has particular protocol) Claudication Toxins, a chelator of lead, mercury, cadmium, and arsenic Glutathione benefits 1
However, numerous challenges persist in terms of safety, efficacy, and targeted precision, warranting concerted advances in basic research and clinical trials
